ロード中...
Orlistat, a New Lipase Inhibitor for the Management of Obesity
Orlistat, a weight-loss agent with a novel mechanism of action, recently was approved by the Food and Drug Administration for the treatment of obesity. It inhibits gastric and pancreatic lipases in the lumen of the gastrointestinal tract to decrease systemic absorption of dietary fat. In several tri...
保存先:
| 出版年: | Pharmacotherapy |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2000
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6145169/ https://ncbi.nlm.nih.gov/pubmed/10730683 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|